Cancer drugs tested for use against zoonotic bioweapons

04/7/2013 | FoxNews.com

Zoonotic illnesses such as monkeypox and Ebola are potential bioweapons, and the Defense Threat Reduction Agency is funding research into how two cancer medications -- Gleevec and Tasigna -- could serve as a defense against such attacks. The idea is that the drugs could slow an infection, allowing the immune system to mount an effective response. Scientists hope to develop a general defense against a variety of potential bioweapons because producing a separate drug for use against each agent is not practical.

View Full Article in:

FoxNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX